Piper Sandler Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)

Research analysts at Piper Sandler initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a note issued to investors on Monday,Benzinga reports. The brokerage set an “overweight” rating and a $27.00 price target on the stock. Piper Sandler’s price target points to a potential upside of 15.24% from the company’s previous close.

Several other analysts also recently issued reports on KMTS. Stifel Nicolaus began coverage on Kestra Medical Technologies in a research note on Monday. They issued a “buy” rating and a $28.00 price target on the stock. The Goldman Sachs Group initiated coverage on Kestra Medical Technologies in a report on Monday. They set a “neutral” rating and a $24.00 price objective for the company.

Kestra Medical Technologies Trading Down 2.5 %

Shares of KMTS stock opened at $23.43 on Monday. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.